Nachrichten zur Abbvie Inc. Aktie

Abbvie Inc (NYSE:ABBV) has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its pipeline…

Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…

Buy, sell, or hold? Thats the question investors must continually ask about each stock in their portfolio. The correct answer might…

I dont know if well be riding in personal aircraft 20 years from now, like George Jetson did in the…

AbbVie (ABBV) closed at $182.31 in the latest trading session, marking a -2.4% move from the prior day.…

Investing in exchange-traded funds (ETFs) is a great way for both new and experienced investors to gain market exposure, and…

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock…

In the most recent trading session, AbbVie (ABBV) closed at $185.48, indicating a -2.82% shift from the previous trading day.…

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Venclexta fails to meet survival goals in ABBVs phase III MDS study, marking another clinical setback for the cancer drug.…

…

…

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.…

Investing in dividend stocks is a great way to generate a steady stream of recurring income for your portfolio. But…

The latest trading day saw AbbVie (ABBV) settling at $191.50, representing a +1.06% change from its previous close.…

…

AbbVie at Goldman Sachs Conference: Strategic Growth and Innovation…

How would you like to get paid every quarter (and sometimes every month) to own a stock? Thats exactly what…

The latest trading day saw AbbVie (ABBV) settling at $187.66, representing a +0.17% change from its previous close.…

The latest trading day saw AbbVie (ABBV) settling at $186.11, representing a +0.26% change from its previous close.…

Dividend growth stocks can be powerful investments. Hartford Funds and Ned Davis Research dug into the data on stocks based…

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.…

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss: Investing in companies with a "singular" leader, like…

Dividend growth stocks have long been reliable engines of wealth creation. Historically, companies with 10-year annualized dividend growth rates above…

Bayer, Novo Nordisk, GSK, Merck and AbbVie are part of the Zacks top Analyst Blog.…

Make money without even trying: Thats what passive income is all about. But good investment alternatives are required to make…

The U.S. Food and Drug Administration has approved AbbVies drug to treat adults with a type of lung cancer who…

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing,…

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to…

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but…